ReviewFrontiers in pharmacology2025

Novel therapeutic strategies targeting resistance mechanisms in hematologic malignancies: from BCL2 inhibition to immunomodulatory approaches.

Qianyu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.